[INQ. NO. 1706C07] Since its establishment in 2002, MACROCARE TECH Co., Ltd., which started producing high-functional cosmetics, pharmaceuticals, and foodstuffs, has moved beyond the domestic market that relies on imports for 80% of cosmetics materials achieving US$5 million in exports in 2016.
Major clients of MACROCARE include major global enterprises such as L’Oreal, Estee Lauder and Amway China, and large domestic companies such as AMOREPACIFIC, LG H & H, KOLMA Korea, and COSMAX.
MACROCARE’s core technologies fall into five categories: Organic synthesis; biotechnology; a technology to purify functional organic materials into membranes and columns; various advanced delivery systems to increase the stability and solubility of materials; and Bioconversion, a technology to produce functional materials using biocatalysts such as enzymes and microorganisms.
MACROCARE secured its position by receiving the highest technology rating of A+ from the Korea Technology Finance Corporation (KOTEC), with about 20 patents including nanotechnology. There are about 40 different kinds of products made in this way with whitening, wrinkle improvement, moisturizing, anti-inflammatory, and stimulation relief effects, etc. Among them, the company is strengthening its research capacity in five product ranges with high market share including V2G, Glucan, Ceramides, Chlorphenesin, Vitagen.
MACROCARE’s latest benefactor is chlorphenesin, the use of which is commonly for the synthesis of pharmaceuticals, as a preservative, instead of preservatives such as parabens, thus enhancing safety when using cosmetics.
It can be used as a cosmetic preservative in place of parabens by removing the disadvantage of its odor through the unique refining technology of MACROCARE. Consequently, the products are highly appreciated by L’Oréal and other global companies and currently on back order.
Korean-Products.com | Blog Magazine of Korean products, brands and Goods